ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Xentria gets US FDA orphan drug designation for XTMAB-16 in sarcoidosis
December 16, 2020Xentria announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for its intravenous TNF-α inhibitor, XTMAB-16, for the treatment of sarcoidosis. -
One Woman's Case Gives New Hope Against Disfiguring Sarcoidosis
December 27, 2018In very preliminary findings, an existing rheumatoid arthritis drug appeared to cure one woman of a rare but potentially life-threatening condition known as sarcoidosis.....
Pharma Sources Insight January 2025
